Table 2.
HR | 95% CI Lower | 95% CI Upper | p | |
---|---|---|---|---|
Univariate analysis: ≥10 vs. <10 LN | ||||
all patients | 0.748 | 0.577 | 0.970 | 0.028 |
no NAC | 0.713 | 0.541 | 0.941 | 0.017 |
NAC | 0.980 | 0.455 | 2.111 | 0.959 |
Multivariate analysis: ≥10 vs. <10 LN | ||||
all patients | 0.714 | 0.549 | 0.930 | 0.012 |
no NAC | 0.718 | 0.542 | 0.952 | 0.021 |
NAC | 0.882 | 0.329 | 2.364 | 0.804 |
Univariate analysis: ≥15 vs. <15 LN | ||||
all patients | 0.742 | 0.583 | 0.945 | 0.015 |
no NAC | 0.729 | 0.564 | 0.943 | 0.016 |
NAC | 0.764 | 0.370 | 1.577 | 0.466 |
Multivariate analysis: ≥15 vs. <15 LN | ||||
all patients | 0.754 | 0.590 | 0.963 | 0.024 |
no NAC | 0.759 | 0.585 | 0.983 | 0.037 |
NAC | 0.695 | 0.296 | 1.628 | 0.402 |
HR: Hazard ratio; NAC: neoadjuvant chemotherapy; LN: lymph nodes; CI: confidence interval.